SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 207 filers reported holding SEATTLE GENETICS INC in Q4 2013. The put-call ratio across all filers is 0.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,000 | -99.7% | 13 | -99.9% | 0.00% | -100.0% |
| Q4 2015 | $741,000 | -7.8% | 15,560 | -3.7% | 0.02% | -15.8% |
| Q3 2015 | $804,000 | -19.7% | 16,160 | -12.5% | 0.02% | -17.4% |
| Q2 2015 | $1,001,000 | +15.2% | 18,460 | +0.1% | 0.02% | +35.3% |
| Q1 2015 | $869,000 | -1.0% | 18,450 | -1.6% | 0.02% | 0.0% |
| Q4 2014 | $878,000 | +4.9% | 18,750 | +16.7% | 0.02% | 0.0% |
| Q3 2014 | $837,000 | -4.1% | 16,060 | 0.0% | 0.02% | -10.5% |
| Q2 2014 | $873,000 | -9.9% | 16,060 | 0.0% | 0.02% | -5.0% |
| Q1 2014 | $969,000 | +149.1% | 16,060 | +66.2% | 0.02% | +150.0% |
| Q4 2013 | $389,000 | +211.2% | 9,662 | +249.8% | 0.01% | +166.7% |
| Q3 2013 | $125,000 | +40.4% | 2,762 | 0.0% | 0.00% | +50.0% |
| Q2 2013 | $89,000 | – | 2,762 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 45,725,556 | $2,487,928,000 | 20.18% |
| Lagoda Investment Management, L.P. | 306,694 | $16,687,000 | 6.03% |
| NEXTHERA CAPITAL LP | 373,000 | $20,295,000 | 5.22% |
| Redmile Group, LLC | 1,843,733 | $100,318,000 | 4.95% |
| Matrix Capital Management Company, LP | 2,118,000 | $115,240,000 | 3.68% |
| Sio Capital Management, LLC | 100,000 | $5,441,000 | 2.82% |
| Opus Point Partners Management, LLC | 41,263 | $2,245,000 | 2.01% |
| Eventide Asset Management | 525,000 | $28,565,000 | 1.62% |
| EMORY UNIVERSITY | 35,982 | $1,958,000 | 1.55% |
| Everett Capital Advisors UK LLP | 191,500 | $10,420,000 | 1.54% |